IGF2BP3 and cancer: Additionally, according to prior studies, the oncofetal protein IGF2BP3 has been reported as a predominant cancer-specific marker differentiating benign from malignant lesions of pancreas and uterine cervix (57, 58), highly indicating that increased IGF2BP3 expression was associated with unfavorable prognosis among tumor tissues.